Literature DB >> 15104374

Adefovir dipivoxil as a treatment for hepatic failure caused by lamivudine-resistant HBV strains.

Reiichiro Kuwahara1, Ryukichi Kumashiro, Hiroto Inoue, Ryo Tanabe, Eisuke Tanaka, Teruko Hino, Tatsuya Ide, Yuriko Koga, Michio Sata.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15104374     DOI： 10.1023/b:ddas.0000017455.39171.56

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  26 in total

Review 1.  Hepatitis B virus infection.

Authors:  W M Lee
Journal:  N Engl J Med       Date:  1997-12-11       Impact factor: 91.245

2.  Lamivudine and alpha-interferon in combination long term for precore mutant chronic hepatitis B.

Authors:  I Tatulli; R Francavilla; G L Rizzo; V Vinciguerra; E Ierardi; A Amoruso; C Panella; A Francavilla
Journal:  J Hepatol       Date:  2001-12       Impact factor: 25.083

3.  Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection.

Authors:  S M Lin; I S Sheen; R N Chien; C M Chu; Y F Liaw
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

4.  Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial.

Authors:  S W Schalm; J Heathcote; J Cianciara; G Farrell; M Sherman; B Willems; A Dhillon; A Moorat; J Barber; D F Gray
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

5.  Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy.

Authors:  D Mutimer; D Pillay; P Cook; D Ratcliffe; K O'Donnell; D Dowling; J Shaw; E Elias; P A Cane
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

6.  Lamivudine as initial treatment for chronic hepatitis B in the United States.

Authors:  J L Dienstag; E R Schiff; T L Wright; R P Perrillo; H W Hann; Z Goodman; L Crowther; L D Condreay; M Woessner; M Rubin; N A Brown
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

Review 7.  Liver disease-significant improvement with lamivudine.

Authors:  N Leung
Journal:  J Med Virol       Date:  2000-07       Impact factor: 2.327

8.  Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis.

Authors:  D K Wong; A M Cheung; K O'Rourke; C D Naylor; A S Detsky; J Heathcote
Journal:  Ann Intern Med       Date:  1993-08-15       Impact factor: 25.391

9.  Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase.

Authors:  Peter Angus; Rhys Vaughan; Shelly Xiong; Huiling Yang; William Delaney; Craig Gibbs; Carol Brosgart; Danielle Colledge; Rosalind Edwards; Anna Ayres; Angeline Bartholomeusz; Stephen Locarnini
Journal:  Gastroenterology       Date:  2003-08       Impact factor: 22.682

10.  A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

Authors:  C L Lai; R N Chien; N W Leung; T T Chang; R Guan; D I Tai; K Y Ng; P C Wu; J C Dent; J Barber; S L Stephenson; D F Gray
Journal:  N Engl J Med       Date:  1998-07-09       Impact factor: 91.245
View more
  4 in total

1.  Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines.

Authors:  Carla S Coffin; Scott K Fung; Mang M Ma
Journal:  Can J Gastroenterol       Date:  2012-12       Impact factor: 3.522

2.  Predictive factors associated with the progression to hepatic failure caused by lamivudine-resistant HBV.

Authors:  Reiichiro Kuwahara; Ryukichi Kumashiro; Tatsuya Ide; Yuriko Koga; Teruko Hino; Akiko Hisamochi; Kazuo Tanaka; Kei Ogata; Hiroyuki Koga; Yukari Takao; Michio Sata
Journal:  Dig Dis Sci       Date:  2008-07-10       Impact factor: 3.199

3.  Management of chronic hepatitis B: consensus guidelines.

Authors:  Morris Sherman; Stephen Shafran; Kelly Burak; Karen Doucette; Winnie Wong; Nigel Girgrah; Eric Yoshida; Eberhard Renner; Philip Wong; Marc Deschênes
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

4.  Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients.

Authors:  Makoto Nakamuta; Kazuhiro Kotoh; Munechika Enjoji; Eiji Kajiwara; Junya Shimono; Akihide Masumoto; Toshihiro Maruyama; Norihiro Furusyo; Hideyuki Nomura; Hironori Sakai; Kazuhiro Takahashi; Koichi Azuma; Shinji Shimoda; Yuichi Tanabe; Jun Hayashi
Journal:  Comp Hepatol       Date:  2007-05-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.